Live within large, complex health systems including BJC HealthCare, Washington University, and Siteman Cancer Center See results
Medication Therapy & Adherence
Patients who understand their therapy, and stay on it
Specialty and injectable therapies fail most often in the first months, for reasons education and timely check-ins can reach. A medication therapy orbit is designed backwards from persistence, calls, and chair utilization.
A trusted digital guide your patients keep, from the first fill through long-term adherence.
Your counseling in your pharmacists' own words, delivered when each instruction actually matters. Alongside the printed leaflet and the counseling call, an orbit adds a consumer-grade digital mentor: engaging video, email, and text outreach that keeps patients informed, reassured, and taking the therapy as prescribed.
Built to your regimens and protocols before launch. Nothing added to your team's day.
One orbit, issued once, working for three audiences at the same time.
For the patient
They know what to do
A clear understanding of what the medication does and why it continues
How to take it, store it, and handle a missed dose, on the day it applies
Which side effects warrant a call rather than stopping the therapy
The same guide works for whoever helps manage the regimen at home
For your team
Nothing added to the day
Ordered from the workflow you already run, no new FTEs
Fewer calls asking what the counseling session already covered
Your protocols and your brand, not a generic pill reminder app
We build and maintain the content, including formulary updates
For the program
You can finally see it
Who opened their orbit and who never did, by patient
Adherence and side effect check-ins routed back between fills
Persistence and refill patterns by therapy and by site
Optional: validated measures scored automatically
How to begin
Start with one, add the rest
Most programs start with their highest-cost or highest-abandonment therapy.
Specialty starts. High-cost therapies where abandonment is most expensive.
Anticoagulation. The regimen where a misunderstanding is most dangerous.
Injectables and GLP-1s. Technique, titration, and side effect expectations.
Refill and persistence. The long tail where most therapies quietly stop.
A patient’s orbit can evolve as their journey needs change
One orbit that changes as the therapy progresses
The same orbit advances through three versions on its own, with no new app or login.
01
PrescribedBefore the first fill
What the therapy is for, what it will cost, prior authorization expectations, and why starting matters.
02
Starting therapyThe first weeks
Technique, timing, titration, and the side effects that are expected rather than a reason to stop.
03
Long-term adherence with PROMsMonth three and beyond
Refill prompts, persistence support, and validated measures collected on schedule and returned to the team.
How it deploys
Issued from the workflow you already run
From the CareOrbit app, a scheduled flat file from any EHR, a patient list, a QR code, or a text message.
No new FTEs. Nothing added to anyone's day.
White-label. Your brand, your voice.
Live in a quarter. From kickoff to first patient.
The understanding gap
The prescription nobody watches.
A prescription is written in minutes and taken for years. Nobody sees the bottle after it leaves the counter, and roughly half of patients on long-term therapy do not take it as prescribed. That is the understanding gap, and the figures below are what it costs.
What the gap costs
None of this is decided at the counter. Each one turns on whether a patient understood what the medication does, handled a side effect without stopping, and refilled it on time.
Minutes
Spent counseling
The only contact most patients get about a medication they will take for years.
50%
Nonadherent on long-term therapy
Roughly half of patients on chronic medication do not take it as prescribed.
Week 2
Where most therapies stop
The first side effect, met without guidance.
Every dose
Taken alone
Timing, food rules, and the decision to keep going, all outside your building.
Measurable ROI
How an orbit provides value.
Every orbit is built based on your target clinical and financial outcomes including revenue to protect, costs to lower, opportunities to expand and staff resources to support.
01
Higher adherence on long-term therapy
Roughly half of chronic medication is not taken as prescribed, and almost none of that is visible to the prescriber.
02
Fewer avoidable admissions
Nonadherence is one of the most consistently cited drivers of preventable hospitalization.
03
Higher refill persistence
A lapse caught at week three is recoverable. One found at the next visit usually is not.
04
Fewer medication errors at home
Timing, food rules, and interactions explained once at the counter and never again.
05
Fewer inbound calls per patient
Every repeat call is pharmacist time spent re-explaining what was already covered.
06
Better performance on adherence measures
Adherence measures carry direct weight in quality and star-rating programs.
07
Safer high-risk regimen use
Anticoagulants, oncolytics, and specialty therapies are where an error costs the most.
08
A visible program differentiator
A branded therapy-management experience is something few competitors can show a payer or a prescriber.
Medication therapy care journeys currently supported.
Support your pharmacy and infusion programs with the Medication Therapy Support Orbit, in patient and family versions, carrying the whole therapy course: what the medication does, what to expect, what to do when side effects hit, and when to refill. [Placeholder: additional orbits in this library to be supplied by the CareOrbit team.]
01
Medication Therapy Support Orbit
Adherence, side effect guidance, and refill support across the therapy course
Clinical evidence
The trial behind the platform.
The platform's controlled trial was run in surgical oncology, not medication therapy. We show it as measured and let you judge the transfer.
Controlled clinical trialSiteman Cancer Center, Washington University School of Medicine
Patients understood the plan, called less, and came back less
A controlled trial in hepatobiliary surgical oncology compared an orbit against usual care, including the medication instructions patients take home. The mechanism is comprehension, not oncology. Applying these percentages to a medication therapy population is a modeled transfer, not a measured adherence result.
From live oncology deployments. Medication therapy orbits are built on the same platform.
Patients see it as incredibly easy to understand and use. We use it to open up dialogues so much faster. Families just run with it!
Chief of Section, Surgical Oncology
It's seen as incredibly easy to understand and use. They (patients and families) just run with it.
Nurse Navigator, Siteman Cancer Center Surgical Department
By the numbers
What better adherence is worth in a year.
Modeled illustration, not observed results
Call-reduction figures are measured in surgical oncology and applied here as a modeled transfer to a medication therapy population.
Worked on 2,000 patients a year at a 10% avoidable admission rate and $12,000 per admission, with half of patients nonadherent. The call reduction is a measured trial outcome; the admission and adherence improvements are modeled. Every rate and unit cost is a figure you supply.
About half
Chronic medication not taken as prescribed
Nonadherence on long-term therapy is one of the most consistently documented failures in medicine, and it is almost entirely invisible between appointments.
World Health Organization and subsequent adherence literature: roughly 50% adherence to long-term therapy in developed countries.
Week 2
Where most therapies quietly stop
The first side effect, met without guidance about whether it fades. Setting the expectation in advance is the cheapest intervention available.
Published discontinuation literature across chronic therapy classes.
−53%
Calls to the clinical line
Measured in the CareOrbit controlled trial. Dosing and side-effect questions the orbit answered first, at three calls per patient and eight minutes each.
CareOrbit controlled clinical trial, Siteman Cancer Center. Applied here as a modeled transfer.
+65%
Understanding of the plan
Measured in the same trial. Understanding is what separates a filled prescription from a therapy that is actually taken.
CareOrbit controlled clinical trial, Siteman Cancer Center.
Modeled annual exposure
$510K
On 2,000 patients a year, at the rates shown below
424 hrs
Pharmacist and nursing time returned over the same year
Worked on 2,000 patients a year at a 10% avoidable admission rate, $12,000 per admission, three calls per patient at eight minutes each, and a $40 loaded hourly staff cost. Substitute your own figures and the totals move accordingly.
No demo script, no obligation. We get introduced, hear which medication therapy & adherence moments are costing your team the most, and give you a brief look at the platform. Then we decide together whether it is worth a second conversation.
